Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Medical Case Reports. 2021, 9(8), 394-396
DOI: 10.12691/AJMCR-9-8-3
Case Report

Immune Thrombocytopenic Pupura after COVID-19 Vaccine, a Case Report

Hafsa Parpia1, Eman EL-Sawalhy1, , Maher Khadra1, Raisa Mayers1, Samyuktha Madishetty1 and Faisal Musa2

1Department of Internal Medicine, Beaumont Hospital, Dearborn, MI

2Division of Hematology & Oncology, Internal Medicine Department, Beaumont Hospital, Dearborn, MI

Pub. Date: April 24, 2021
Full Text PDF

Cite this paper

Hafsa Parpia, Eman EL-Sawalhy, Maher Khadra, Raisa Mayers, Samyuktha Madishetty and Faisal Musa. Immune Thrombocytopenic Pupura after COVID-19 Vaccine, a Case Report. American Journal of Medical Case Reports. 2021; 9(8):394-396. doi: 10.12691/AJMCR-9-8-3

Abstract

Immune Thrombocytopenic Purpura (ITP) is an autoimmune disorder caused by different entities, one of them being the administration of certain vaccines, most commonly MMR vaccines that have been linked with the development of this disease. We report a 26-year-old female presented to the hospital with a petechial rash and mucosal bleeding after three weeks of administration of the COVID-19 vaccine. Thrombocytopenia workup was done, ITP was diagnosed. The ITP in this case was refractory to initial treatment of IVIG and steroid. Rituximab was initiated and she had an excellent response to it.

Keywords

ITP, bleeding, COVID vaccine, rituximab

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Baden, L; El Sahly, H; Essink, B et all, “Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine”, The New England Journal of Medicine, 384 (5). 403-416.Feb.2021.
 
[2]  Ramasamy, M., Minassian, A., Ewer, K., Flaxman, A. et all, “Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults(COV002): a single-blind, randomized, controlled, phase 2/3 trial”, The Lancet, 396(10267). 1979-1993. Dec.2020.
 
[3]  Di Pietrantonj, C., Rivetti, A., Marchione, P., Debalini, MG., Demicheli, V. “Vaccines for measles, mumps, rubella, and varicella in children”. Cochrane Database Syst Rev.
 
[4]  Hamiel, U., Kventsel, I., Youngster, I. “Recurrent immune thrombocytopenia after influenza vaccination: a case report”. Pediatrics. 138(6), Nov.2016. [Online].
 
[5]  The New York Times. A Few Covid Vaccine Recipients Developed a Rare Blood Disorder”. Feb 2021. [Online]
 
[6]  Mantadakis, E., Farmaki, E., Thomaidis, S., Tsalkidis, A., Chatzimichael, A. “A Case of Immune Thrombocytopenic Purpura After Influenza Vaccination”, Journal of Pediatric Hematology/Oncology, 32(6). 227-229. Aug.2010.
 
[7]  Shimabukuro, TT., Cole, M., Su, JR. “Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US”, JAMA, 325(11). 1101-1102. Jan. 2021.
 
[8]  American Society of Hematology. “COVID-19 resources”. January 2021.